How do you pay?

How to pay the least

Ask for the cash price

Anzupgo

We didn’t find one.

  1. Ask your pharmacy for Anzupgo’s cash price, and one or two other pharmacies too.
  2. Anzupgo’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameAnzupgo
Authorized genericdelgocitinib
Regular genericdelgocitinib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Anzupgo?
The original
–
–

Brand nameThe maker’s card

ANZUPGO Copay Program

Savings card from LEO Pharma

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

Sign up on anzupgo.com 

In the maker’s words

“Patients may pay as little as $0 per fill of the Product after application of Program reimbursement.”

From the maker’s offer on anzupgo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Anzupgo itself, from the same company, sold without the brand name, and usually for less. For now Anzupgo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ANZUPGO is a Janus kinase (JAK) inhibitor indicated for the topical treatment of moderate to severe chronic hand eczema (CHE) in adults who have had an inadequate response to, or for whom topical corticosteroids are not advisable.

Limitations of Use: Use of ANZUPGO in combination with other JAK inhibitors or potent immunosuppressants is not recommended.

Source: the FDA label for Anzupgo (LEO Pharma, Inc), July 10, 2026. Full label on DailyMed 

Good to know